https://clinicaltrials.gov/ct2/show/NCT03963375?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Conditions : Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Intervention : Drug: Cladribine
Sponsor : Washington University School of Medicine
Not yet recruiting
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
NCT03963375
Fri, 24 May 2019 12:00:00 EDT
First Added: 05/24/19 06:51AM